Medical pharmacy is a rapidly evolving, innovative part of healthcare in the United States that includes Oncology, Gene, and Rare disease therapies. Over the past few years, cost and utilization trends have been disrupted by biosimilars, innovative therapies, site of care options, and the COVID-19 pandemic. This volatility can make assumption setting difficult, so take a deep dive into quantifying these impacts on the drug landscape. Gain an understanding of the significance of managing site of care. Learn through adjusted time-series forecasting where medical pharmacy drug spend is expected to grow with new drugs in the pipeline. Walk away with a better understanding of the market forces and care practices that drive trend, and how medical pharmacy is expected to change in the coming years.
By attending the session, you will be able to:Better understand how the COVID-19 pandemic has impacted utilization, how the launch of biosimilar drugs has impacted costs, and a forecast of medical drug costs for the coming years.
TRACK: Spearheading innovation through change, Cultivating future opportunities